# Deferasirox

NDC: 69238-1487
Generic name: Deferasirox
Labeler / Manufacturer: Amneal Pharmaceuticals NY LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20200615

FDA application: ANDA210727

## Active ingredients

- DEFERASIROX: 180 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69238-1487"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69238-1487
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7ae9c31-e14f-4cf9-9ab3-850519f1a87c